Health insurance status and hearing aid utilization in U.S. older adults: A population-based cross-sectional study
PLOS One · 2026
DOI: 10.1371/journal.pone.0341570 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS One, 2026. Verfasst von Kaitlin Hori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America. Hauptthemen laut MEDLINE: Hearing Aids, Insurance Coverage, Hearing Loss, Insurance, Health. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
The role of health insurance and its diverse hearing health benefits on hearing aid utilization is currently unknown. The objective of this study is to examine rates of ever and regular hearing aid (HA) use by insurance status in older U.S. adults.
Methods
This cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) (2005–2018). Older adults (≥65 years) with complete data on health insurance, audiometry, and hearing aid use (n = 3,172) were included. Eight combinatorial insurance categories were created and compared pairwise to the reference of Medicare only coverage. Outcomes included ever and regular hearing aid use.
Results
Among older U.S. adults, 30.3% [95% CI:27.6%−33.2%] of those with audiometry-measured hearing loss reported ever using HAs while 22.9% [95% CI:20.3%−25.7%] reported regular HA use. Among older adults with hearing loss, those with military-related insurance (Tricare, VA and Champ-VA) had amongst the highest rates of ever and regular HA use (43.3% [95% CI:31.3%−56.2%] and 30.8% [95% CI:21.1%−42.5%], respectively). Ever HA use rates for individuals with Medicare and Medicaid was 30.8% [95% CI:27.8%−33.8%] and 17.7% [95% CI:11.9%−25.5%], respectively. In a multivariable model adjusting for demographics and hearing loss severity, individuals with military-related and military-related+Medicaid insurance were significantly more likely to report ever using HAs compared to those with Medicare only (OR 1.80, 95% CI:1.03–3.16; OR 20.38, 95% CI:1.07–386.84, respectively). Those with military-related insurance were more likely to report regular HA use (OR 2.17, 95% CI:1.16–4.09).
Conclusion
In this nationally representative study of older U.S. adults, we found differences in ever and regular HA use rates by insurance status, even when adjusting for hearing loss, demographics, and comorbidities. Future research is warranted to investigate group-specific differences, including access to hearing care, hearing health benefits, and stigma, to better understand the facilitators and barriers to hearing aid use by insurance status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
- Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic Arizona, Phoenix, Arizona, United States of America.
- Caruso Department of Otolaryngology-Head and Neck Surgery, University of Southern California, Los Angeles, California, United States of America.
ORCID-Profile: Kaitlin Hori, Diego E Razura
Zitieren
APA
Hori, K., Li, A., Razura, D. E., Parsons, J., & Choi, J. S. (2026). Health insurance status and hearing aid utilization in U.S. older adults: A population-based cross-sectional study. PLOS One. https://doi.org/10.1371/journal.pone.0341570
Vancouver
Hori K, Li A, Razura DE, Parsons J, Choi JS. Health insurance status and hearing aid utilization in U.S. older adults: A population-based cross-sectional study. PLOS One. 2026. doi:10.1371/journal.pone.0341570
BibTeX
@article{Hori2026,
author = {Hori, Kaitlin and Li, Albert and Razura, Diego E and Parsons, John and Choi, Janet S},
title = {Health insurance status and hearing aid utilization in U.S. older adults: A population-based cross-sectional study},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0341570}
}
EUVIMED